The Endocrine Society Publishes Seven Clinical Practice Guidelines

To date, seven Clinical Practice Guidelines (CPGs) have been published and three other guidelines have been approved by The Endocrine Society's Council. There are currently eight other CPGs in various stages of development; including two CPGs that are being revised.

Published Guidelines:

• Evaluation & Treatment of Adult Growth Hormone Deficiency – Mark Molitch, MD, Chair
• Testosterone Therapy in Adult Men with Androgen Deficiency Syndrome – Shalender Bhasin, MD, Chair
• Androgen Therapy in Women – Margaret Wierman, MD, Chair
• Management of Thyroid Dysfunction during Pregnancy & Postpartum – Leslie DeGroot, MD, Chair
• Evaluation & Treatment of Hirsutism in Premenopausal Women – Kathryn Martin, MD, Chair
• Diagnosis of Cushing's Syndrome – Lynette Nieman, MD, Chair
• Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism – John Funder, MD
  

Guideline Approved by the Council & Accepted for Publishing  in JCEM:

• Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk – James Rosenzweig, MD, Chair

Guidelines Approved by Council:

• Prevention & Treatment of Pediatric Obesity – Gilbert August, MD, Chair
• Evaluation and Management of Adult Hypoglycemic Disorders – Philip Cryer, MD, Chair

Guidelines in Progress:

• Congenital Adrenal Hyperplasia – Phyllis Speiser, MD, Chair
• Continuous Glucose Monitoring – David C. Klonoff, MD, FACP, Chair
• Endocrine Treatment of Adolescent & Adult Transsexuals – Wylie Hembree, MD, Chair
• Post Bariatric Surgery – David Heber, MD, Chair
• Pituitary Incidentaloma – Pamela Freda, MD, Chair
• Vitamin D & Bone – Mike Holick, MD, Chair

Each guideline is created by a task force whose membership consists of experts in the field. These task forces rely on evidence-based reviews of the literature to provide support for the recommendations. The Society has contracted with the Knowledge and Encounter Research Unit of the Mayo Clinic College of Medicine, which uses the GRADE scheme for evidence review. This system takes into account relative strengths and weaknesses of the best available evidence. The GRADE scheme was recognized in ACP Journal Club as a state of the art approach that is "rigorous in its methodology, yet practical to use."

Although the CPGs are not available for support, The Endocrine Society currently has plans to work with health education media companies to produce enduring products to the Society's Guidelines. These enduring products are available for support and will serve to increase awareness and potential usage of the guidelines and include items such as wall charts and pocket guides for physicians.

The Hormone Foundation also develops patient companion pieces to complement each CPG. These guides are designed to help patients with specific endocrine-disorders to partner with their physicians to reach their treatment goals. The Hormone Foundation patient guides are available for support and offer a unique opportunity for public exposure through patient education efforts.

Please contact Anna Meenan at 301-951-2619 or ameenan@endo-society.org for more information on supporting guideline enduring materials or patient companion pieces.